Rwanda vs Slovak Republic: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Rwanda
96.0%
in 2025
Slovak Republic
96.0%
in 2025
Rwanda rank
26th
Slovak Republic rank
26th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Rwanda
- Slovak Republic
How they compare
Rwanda currently reports 96.0% against 96.0% in Slovak Republic, a difference of 0.0%.
The two have swapped places 6 times across 18 shared years of data; in 2008 it was Slovak Republic ahead.
Rwanda ranks 26th and Slovak Republic ranks 26th of 192 countries.
Across the 3 decades both report, Rwanda averaged higher in 1 and Slovak Republic in 2.
Head to head by decade
| Decade | Rwanda | Slovak Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 49.5% | 49.5% | Slovak Republic |
| 2010s | 97.7% | 97.3% | 0.4% | Rwanda |
| 2020s | 94.0% | 96.2% | 2.2% | Slovak Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Rwanda or Slovak Republic?
- Rwanda, at 96.0% against 96.0% in Slovak Republic as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Rwanda and Slovak Republic?
- 0.0%, with Rwanda ahead.
- How many years of comparable data are there for Rwanda and Slovak Republic?
- 18 years are reported by both, from 2008 to 2025.
- How do Rwanda and Slovak Republic rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Rwanda ranks 26th and Slovak Republic ranks 26th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.